Genitourinary Cancers

BIOGRAPHY

ACADEMIC POSITION:
Professor, Beth and Dave Swalm Chair in Urologic Oncology

EDUCATION:
• BA, University of Texas, Austin, TX
• MD, Baylor College of Medicine, Houston, Surgical Residency, Virginia Mason Hospital, Seattle, WA
• Urology Residency, Baylor College of Medicine, Houston, TX
• Fellowship (urologic oncology), USC School of Medicine Board Certified

MEMBERSHIPS/EDITORIAL POSITIONS:
• Director of SDU's Program of Continuing Medical Education
• Co-Chair, Bladder Cancer Disease Working Group for the Cancer Genome Atlas Project (NCI)
• Co-Chair, Testis Committee, Southwest Oncology Group
• Board of Consultants, Journal of Urology
• Section Editor, Urologic Oncology
• Editorial Board, British Journal of Urology International

RESEARCH INTERESTS:
• Role of estrogen receptors and the use of selective estrogen receptor modulators (e.g. tamoxifen) for treatment of bladder cancer
• Novel targeted therapeutics and gene therapy for treatment of non-muscle-invasive and invasive disease
• Outcome of treatments for non-muscle-invasive bladder cancer and radical cystectomy and development of predictive models
• Bladder cancer screening for high-risk subjects
• Tissue engineering and development of 'off the shelf replacement parts' for urinary tract reconstruction